Table 3.
Individual and mean plasma pharmacokinetics of sildenafil, UK-103,320 and UK-150,564 following IV administration of 25-mg sildenafil.
| Parameter | Sildenafil | UK-103,320 | UK-150,564 |
|---|---|---|---|
| Cmax (ng ml−1) | |||
| Subject 1 | 455 | 41 | 31 |
| Subject 2 | 565 | 32 | 15 |
| Subject 3 | 540 | 43 | 15 |
| Geometric Mean | 518 | 38 | 19 |
| AUC (ng h ml−1) | |||
| Subject 1 | 928 | 119 | 124 |
| Subject 2 | 1051 | 136 | 76 |
| Subject 3 | 939 | 198 | 67 |
| Geometric Mean | 971 | 147 | 86 |
| Tmax (h) | |||
| Subject 1 | 0.42 | 0.75 | 0.75 |
| Subject 2 | 0.42 | 1.00 | 0.75 |
| Subject 3 | 0.42 | 0.75 | 1.00 |
| Arithmetic Mean | 0.42 | 0.83 | 0.83 |
| t1/2 (h) | |||
| Subject 1 | 1.69 | 1.97 | 7.24 |
| Subject 2 | 3.61 | 2.86 | 7.32 |
| Subject 3 | 1.96 | 2.18 | 3.59 |
| Harmonic Mean | 2.18 | 2.28 | 5.42 |